Filed: 2/14/2024ACC: 0001214659-24-002814
📋 What this filing means
CUTTER CAPITAL MANAGEMENT, LP filed this quarterly 13F‑HR report disclosing 23 equity positions with a total reported market value of $209.17M. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
23
Positions
$209.17M
Total AUM (reported)
9.15M
Total Shares
Allocation by class
COM$148.55M71.0%
SHS$19.60M9.4%
COM PAR $.01$12.81M6.1%
SPONSORED ADS$11.08M5.3%
SHS CLASS A$10.39M5.0%
NAMEN AKT$6.73M3.2%
Portfolio Concentration
Top 3$44.81M21.4%
4–10$79.50M38.0%
11–25$84.86M40.6%
Top 3 weight
21.4%
Top 10 weight
59.4%
Voting Authority Distribution
Total shares with voting rights: 9.15M
Sole
Full voting authority
9.15M
shares
% of voting shares100.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole23
Shared0
Other0
Dominant voting typeSole · 100.0% of voting shares
Institutional Holdings23
Rows:
AMGEN INC
SOLEShares57.38K
TypeSH
Market value$16.53M
7.90%
Sole
57.38K
Shared
0.00
None
0.00
MERCK & CO INC
SOLEShares136.10K
TypeSH
Market value$14.84M
7.09%
Sole
136.10K
Shared
0.00
None
0.00
AMICUS THERAPEUTICS INC
SOLEShares947.42K
TypeSH
Market value$13.44M
6.43%
Sole
947.42K
Shared
0.00
None
0.00
INSMED INC
SOLEShares413.50K
TypeSH
Market value$12.81M
6.13%
Sole
413.50K
Shared
0.00
None
0.00
BIOMARIN PHARMACEUTICAL INC
SOLEShares129.91K
TypeSH
Market value$12.53M
5.99%
Sole
129.91K
Shared
0.00
None
0.00
ROIVANT SCIENCES LTD
SOLEShares1M
TypeSH
Market value$11.23M
5.37%
Sole
1M
Shared
0.00
None
0.00
EXELIXIS INC
SOLEShares462.31K
TypeSH
Market value$11.09M
5.30%
Sole
462.31K
Shared
0.00
None
0.00
TEVA PHARMACEUTICAL INDS LTD
SOLEShares1.06M
TypeSH
Market value$11.08M
5.30%
Sole
1.06M
Shared
0.00
None
0.00
ROYALTY PHARMA PLC
SOLEShares370K
TypeSH
Market value$10.39M
4.97%
Sole
370K
Shared
0.00
None
0.00
ACADIA PHARMACEUTICALS INC
SOLEShares330.97K
TypeSH
Market value$10.36M
4.95%
Sole
330.97K
Shared
0.00
None
0.00
BIOCRYST PHARMACEUTICALS INC
SOLEShares1.52M
TypeSH
Market value$9.12M
4.36%
Sole
1.52M
Shared
0.00
None
0.00
HALOZYME THERAPEUTICS INC
SOLEShares240.45K
TypeSH
Market value$8.89M
4.25%
Sole
240.45K
Shared
0.00
None
0.00
PERRIGO CO PLC
SOLEShares260K
TypeSH
Market value$8.37M
4.00%
Sole
260K
Shared
0.00
None
0.00
PFIZER INC
SOLEShares265K
TypeSH
Market value$7.63M
3.65%
Sole
265K
Shared
0.00
None
0.00
BRISTOL-MYERS SQUIBB CO
SOLEShares140K
TypeSH
Market value$7.18M
3.43%
Sole
140K
Shared
0.00
None
0.00
CRISPR THERAPEUTICS AG
SOLEShares107.50K
TypeSH
Market value$6.73M
3.22%
Sole
107.50K
Shared
0.00
None
0.00
VIRIDIAN THERAPEUTICS INC
SOLEShares307.72K
TypeSH
Market value$6.70M
3.20%
Sole
307.72K
Shared
0.00
None
0.00
APELLIS PHARMACEUTICALS INC
SOLEShares108K
TypeSH
Market value$6.46M
3.09%
Sole
108K
Shared
0.00
None
0.00
IOVANCE BIOTHERAPEUTICS INC
SOLEShares677.35K
TypeSH
Market value$5.51M
2.63%
Sole
677.35K
Shared
0.00
None
0.00
CABALETTA BIO INC
SOLEShares230K
TypeSH
Market value$5.22M
2.50%
Sole
230K
Shared
0.00
None
0.00
PRESTIGE CONSMR HEALTHCARE I
SOLEShares85K
TypeSH
Market value$5.20M
2.49%
Sole
85K
Shared
0.00
None
0.00
BRIDGEBIO PHARMA INC
SOLEShares103.32K
TypeSH
Market value$4.17M
1.99%
Sole
103.32K
Shared
0.00
None
0.00
ARCUS BIOSCIENCES INC
SOLEShares192.67K
TypeSH
Market value$3.68M
1.76%
Sole
192.67K
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
AMGEN INCSOLE | COM | 57.38K | SH | $16.53M 7.90% | 57.38K | 0.00 | 0.00 |
MERCK & CO INCSOLE | COM | 136.10K | SH | $14.84M 7.09% | 136.10K | 0.00 | 0.00 |
AMICUS THERAPEUTICS INCSOLE | COM | 947.42K | SH | $13.44M 6.43% | 947.42K | 0.00 | 0.00 |
INSMED INCSOLE | COM PAR $.01 | 413.50K | SH | $12.81M 6.13% | 413.50K | 0.00 | 0.00 |
BIOMARIN PHARMACEUTICAL INCSOLE | COM | 129.91K | SH | $12.53M 5.99% | 129.91K | 0.00 | 0.00 |
ROIVANT SCIENCES LTDSOLE | SHS | 1M | SH | $11.23M 5.37% | 1M | 0.00 | 0.00 |
EXELIXIS INCSOLE | COM | 462.31K | SH | $11.09M 5.30% | 462.31K | 0.00 | 0.00 |
TEVA PHARMACEUTICAL INDS LTDSOLE | SPONSORED ADS | 1.06M | SH | $11.08M 5.30% | 1.06M | 0.00 | 0.00 |
ROYALTY PHARMA PLCSOLE | SHS CLASS A | 370K | SH | $10.39M 4.97% | 370K | 0.00 | 0.00 |
ACADIA PHARMACEUTICALS INCSOLE | COM | 330.97K | SH | $10.36M 4.95% | 330.97K | 0.00 | 0.00 |
BIOCRYST PHARMACEUTICALS INCSOLE | COM | 1.52M | SH | $9.12M 4.36% | 1.52M | 0.00 | 0.00 |
HALOZYME THERAPEUTICS INCSOLE | COM | 240.45K | SH | $8.89M 4.25% | 240.45K | 0.00 | 0.00 |
PERRIGO CO PLCSOLE | SHS | 260K | SH | $8.37M 4.00% | 260K | 0.00 | 0.00 |
PFIZER INCSOLE | COM | 265K | SH | $7.63M 3.65% | 265K | 0.00 | 0.00 |
BRISTOL-MYERS SQUIBB COSOLE | COM | 140K | SH | $7.18M 3.43% | 140K | 0.00 | 0.00 |
CRISPR THERAPEUTICS AGSOLE | NAMEN AKT | 107.50K | SH | $6.73M 3.22% | 107.50K | 0.00 | 0.00 |
VIRIDIAN THERAPEUTICS INCSOLE | COM | 307.72K | SH | $6.70M 3.20% | 307.72K | 0.00 | 0.00 |
APELLIS PHARMACEUTICALS INCSOLE | COM | 108K | SH | $6.46M 3.09% | 108K | 0.00 | 0.00 |
IOVANCE BIOTHERAPEUTICS INCSOLE | COM | 677.35K | SH | $5.51M 2.63% | 677.35K | 0.00 | 0.00 |
CABALETTA BIO INCSOLE | COM | 230K | SH | $5.22M 2.50% | 230K | 0.00 | 0.00 |
PRESTIGE CONSMR HEALTHCARE ISOLE | COM | 85K | SH | $5.20M 2.49% | 85K | 0.00 | 0.00 |
BRIDGEBIO PHARMA INCSOLE | COM | 103.32K | SH | $4.17M 1.99% | 103.32K | 0.00 | 0.00 |
ARCUS BIOSCIENCES INCSOLE | COM | 192.67K | SH | $3.68M 1.76% | 192.67K | 0.00 | 0.00 |